Literature DB >> 23685212

Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Markus-Frederik Bohn1, Shivender M D Shandilya, John S Albin, Takahide Kouno, Brett D Anderson, Rebecca M McDougle, Michael A Carpenter, Anurag Rathore, Leah Evans, Ahkillah N Davis, Jingying Zhang, Yongjian Lu, Mohan Somasundaran, Hiroshi Matsuo, Reuben S Harris, Celia A Schiffer.   

Abstract

Human APOBEC3F is an antiretroviral single-strand DNA cytosine deaminase, susceptible to degradation by the HIV-1 protein Vif. In this study the crystal structure of the HIV Vif binding, catalytically active, C-terminal domain of APOBEC3F (A3F-CTD) was determined. The A3F-CTD shares structural motifs with portions of APOBEC3G-CTD, APOBEC3C, and APOBEC2. Residues identified to be critical for Vif-dependent degradation of APOBEC3F all fit within a predominantly negatively charged contiguous region on the surface of A3F-CTD. Specific sequence motifs, previously shown to play a role in Vif susceptibility and virion encapsidation, are conserved across APOBEC3s and between APOBEC3s and HIV-1 Vif. In this structure these motifs pack against each other at intermolecular interfaces, providing potential insights both into APOBEC3 oligomerization and Vif interactions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685212      PMCID: PMC3805256          DOI: 10.1016/j.str.2013.04.010

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  63 in total

Review 1.  The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

Authors:  Ya-Lin Chiu; Warner C Greene
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

2.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

3.  Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.

Authors:  Kuan-Ming Chen; Elena Harjes; Phillip J Gross; Amr Fahmy; Yongjian Lu; Keisuke Shindo; Reuben S Harris; Hiroshi Matsuo
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

4.  Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

Authors:  Eri Miyagi; Sandrine Opi; Hiroaki Takeuchi; Mohammad Khan; Ritu Goila-Gaur; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

5.  Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.

Authors:  Lauren G Holden; Courtney Prochnow; Y Paul Chang; Ronda Bransteitter; Linda Chelico; Udayaditya Sen; Raymond C Stevens; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2008-10-12       Impact factor: 49.962

6.  Functional domain organization of human APOBEC3G.

Authors:  Barry D Gooch; Bryan R Cullen
Journal:  Virology       Date:  2008-07-18       Impact factor: 3.616

7.  The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.

Authors:  April J Schumacher; Guylaine Haché; Donna A Macduff; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

8.  Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.

Authors:  Hendrik Huthoff; Michael H Malim
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 9.  The AID/APOBEC family of nucleic acid mutators.

Authors:  Silvestro G Conticello
Journal:  Genome Biol       Date:  2008-06-17       Impact factor: 13.583

10.  APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.

Authors:  Yanxing Han; Xiaojun Wang; Ying Dang; Yong-Hui Zheng
Journal:  PLoS Pathog       Date:  2008-07-04       Impact factor: 6.823

View more
  62 in total

1.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

2.  Conformational Dynamics of the HIV-Vif Protein Complex.

Authors:  K Aurelia Ball; Lieza M Chan; David J Stanley; Elise Tierney; Sampriti Thapa; Hai M Ta; Lily Burton; Jennifer M Binning; Matthew P Jacobson; John D Gross
Journal:  Biophys J       Date:  2019-03-23       Impact factor: 4.033

3.  Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.

Authors:  Erez Pery; Ann Sheehy; N Miranda Nebane; Andrew Jay Brazier; Vikas Misra; Kottampatty S Rajendran; Sara J Buhrlage; Marie K Mankowski; Lynn Rasmussen; E Lucile White; Roger G Ptak; Dana Gabuzda
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 4.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

5.  Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.

Authors:  William C Solomon; Wazo Myint; Shurong Hou; Tapan Kanai; Rashmi Tripathi; Nese Kurt Yilmaz; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

6.  Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.

Authors:  Xiuxiu Lu; Tianlong Zhang; Zeng Xu; Shanshan Liu; Bin Zhao; Wenxian Lan; Chunxi Wang; Jianping Ding; Chunyang Cao
Journal:  J Biol Chem       Date:  2014-12-25       Impact factor: 5.157

7.  Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.

Authors:  Fumiaki Ito; Yang Fu; Shen-Chi A Kao; Hanjing Yang; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-05-04       Impact factor: 5.469

8.  The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; Tania V Silvas; Ellen A Nalivaika; Takahide Kouno; Brian A Kelch; Sean P Ryder; Nese Kurt-Yilmaz; Mohan Somasundaran; Celia A Schiffer
Journal:  Structure       Date:  2015-04-23       Impact factor: 5.006

9.  Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Authors:  Shurong Hou; Tania V Silvas; Florian Leidner; Ellen A Nalivaika; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2018-12-11       Impact factor: 6.006

10.  Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.

Authors:  Sachini U Siriwardena; Thisari A Guruge; Ashok S Bhagwat
Journal:  J Mol Biol       Date:  2015-08-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.